Related Experiment Video
Updated: Jun 20, 2026
06:51
Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
[Why some proton pump inhibitors are more equal than others]
Marten H Otten1, J F F Frits Lekkerkerker, Chris J J Mulder
1Meander Medisch Centrum, afd. Maag-, Darm- en Leverziekten, Amersfoort, The Netherlands. mh.otten@meandermc.nl
Nederlands Tijdschrift Voor Geneeskunde
|September 30, 2009
Summary
Generic proton pump inhibitors (PPIs) may cause increased reflux symptoms due to formulation differences. This can lead to treatment failure and adverse events like dysphagia.
Area of Science:
- Gastroenterology
- Pharmacology
- Drug Efficacy
Background:
- The expiration of the omeprazole patent led to widespread use of generic proton pump inhibitors (PPIs).
- Clinicians observed an increase in gastroesophageal reflux disease (GERD) symptoms following generic PPI substitution.
Observation:
- Two patients, aged 61 and 59, presented with dysphagia, a critical symptom, after receiving generic omeprazole or pantoprazole.
- These patients experienced treatment failure with generic proton pump inhibitors.
Findings:
- Potential reasons for PPI substitution inadequacy include biphasic metabolism affecting drug inactivation, variations in enteric coating affecting acid resistance, and cumulative effects from multiple dosing.
- These factors can alter drug absorption and clinical outcomes.
Implications:
- Generic PPI substitution may lead to suboptimal treatment and increased risk of adverse events.
- Further research is needed to ensure the bioequivalence and clinical effectiveness of generic PPIs.
Related Concept Videos
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:17Pore Transport and Ion-Pair Transport
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
01:16Bioequivalence: Overview
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.